PL410626A1 - Zastosowanie rutynozydu 7-hesperytyny - Google Patents
Zastosowanie rutynozydu 7-hesperytynyInfo
- Publication number
- PL410626A1 PL410626A1 PL410626A PL41062614A PL410626A1 PL 410626 A1 PL410626 A1 PL 410626A1 PL 410626 A PL410626 A PL 410626A PL 41062614 A PL41062614 A PL 41062614A PL 410626 A1 PL410626 A1 PL 410626A1
- Authority
- PL
- Poland
- Prior art keywords
- rutinoside
- hesperetin
- application
- preparation
- hesperitin
- Prior art date
Links
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 title 1
- 208000000913 Kidney Calculi Diseases 0.000 abstract 1
- 206010029148 Nephrolithiasis Diseases 0.000 abstract 1
- OVVGHDNPYGTYIT-ROUHPGRKSA-N alpha-L-Rhap-(1->6)-D-Glcp Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 OVVGHDNPYGTYIT-ROUHPGRKSA-N 0.000 abstract 1
- 229960001587 hesperetin Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest zastosowanie rutynozydu 7-hesperytyny lub jej farmaceutycznie dopuszczalnych soli do wytwarzania preparatu do zapobiegania lub leczenia kamicy nerkowej.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL410626A PL224146B1 (pl) | 2014-12-23 | 2014-12-23 | Zastosowanie rutynozydu 7-hesperytyny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL410626A PL224146B1 (pl) | 2014-12-23 | 2014-12-23 | Zastosowanie rutynozydu 7-hesperytyny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL410626A1 true PL410626A1 (pl) | 2015-07-20 |
| PL224146B1 PL224146B1 (pl) | 2016-11-30 |
Family
ID=53541434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL410626A PL224146B1 (pl) | 2014-12-23 | 2014-12-23 | Zastosowanie rutynozydu 7-hesperytyny |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL224146B1 (pl) |
-
2014
- 2014-12-23 PL PL410626A patent/PL224146B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL224146B1 (pl) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501151A1 (en) | Tank-binding kinase inhibitor compounds | |
| MX2016015862A (es) | Compuestos inhibidores de la cinasa de union a tank. | |
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| IL250085A0 (en) | New compounds of proton tyrosine kinase inhibitor | |
| IL255831A (en) | Inhibitors of bruton's tyrosine kinase | |
| IL248546B (en) | A multi-fluorinated compound as an inhibitor of proton tyrosine kinase | |
| EP3174539A4 (en) | Inhibitors of bruton's tyrosine kinase | |
| EP3141546A4 (en) | Inhibitor of bruton's tyrosine kinase | |
| UY36330A (es) | Compuestos inhibidores de quinasa de unión a tank | |
| MA41350A (fr) | Synthèse d'un inhibiteur de la tyrosine kinase de bruton | |
| IL259863B (en) | Polycyclic compounds as inhibitors of proton tyrosine kinase | |
| EA201790982A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| PH12017500120A1 (en) | Methods of improving myocardial performance in fontan patients using udenafil compositions | |
| EA201890364A1 (ru) | СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t | |
| PT3130592T (pt) | Análogos do composto 4h-pirazolo[1,5-]benzimidazole como inibidores de parp | |
| EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
| EA201691493A1 (ru) | Замещенные n-арилпиридиноны | |
| DE112015002229A5 (de) | Formulierungen zur Behandlung von Hyperthyreose | |
| NZ721832A (en) | Solid forms of tenofovir | |
| EA201790020A1 (ru) | Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний | |
| PL410626A1 (pl) | Zastosowanie rutynozydu 7-hesperytyny | |
| EA201791596A1 (ru) | Пиразоловые соединения | |
| PL410628A1 (pl) | Zastosowanie glikozydu 6-eskuletyny | |
| IN2014CH01391A (pl) |